IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0004710.html
   My bibliography  Save this article

Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup

Author

Listed:
  • M Chehani Alles
  • Margaret Gardiner-Garden
  • David J Nott
  • Yixin Wang
  • John A Foekens
  • Robert L Sutherland
  • Elizabeth A Musgrove
  • Christopher J Ormandy

Abstract

Background: Breast cancers lacking the estrogen receptor (ER) can be distinguished from other breast cancers on the basis of poor prognosis, high grade, distinctive histopathology and unique molecular signatures. These features further distinguish estrogen receptor negative (ER−) tumor subtypes, but targeted therapy is currently limited to tumors over-expressing the ErbB2 receptor. Methodology/Principal Findings: To uncover the pathways against which future therapies could be developed we undertook a meta-analysis of gene expression from five large microarray datasets relative to ER status. A measure of association with ER status was calculated for every Affymetrix HG-U133A probe set and the pathways that distinguished ER− tumors were defined by testing for enrichment of biologically defined gene sets using Gene Set Enrichment Analysis (GSEA). As expected, the expression of the direct transcriptional targets of the ER was muted in ER− tumors, but the expression of genes indirectly regulated by estrogen was enhanced. We also observed enrichment of independent MYC- and E2F-driven transcriptional programs. We used a cell model of estrogen and MYC action to define the interaction between estrogen and MYC transcriptional activity in breast cancer. We found that the basal subgroup of ER− breast cancer showed a strong MYC transcriptional response that reproduced the indirect estrogen response seen in estrogen receptor positive (ER+) breast cancer cells. Conclusions/Significance: Increased transcriptional activity of MYC is a characteristic of basal breast cancers where it mimics a large part of an estrogen response in the absence of the ER, suggesting a mechanism by which these cancers achieve estrogen-independence and providing a potential therapeutic target for this poor prognosis sub group of breast cancer.

Suggested Citation

  • M Chehani Alles & Margaret Gardiner-Garden & David J Nott & Yixin Wang & John A Foekens & Robert L Sutherland & Elizabeth A Musgrove & Christopher J Ormandy, 2009. "Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup," PLOS ONE, Public Library of Science, vol. 4(3), pages 1-13, March.
  • Handle: RePEc:plo:pone00:0004710
    DOI: 10.1371/journal.pone.0004710
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004710
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0004710&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0004710?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zinab O. Doha & Xiaoyan Wang & Nicholas L. Calistri & Jennifer Eng & Colin J. Daniel & Luke Ternes & Eun Na Kim & Carl Pelz & Michael Munks & Courtney Betts & Sunjong Kwon & Elmar Bucher & Xi Li & Tre, 2023. "MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    2. Seyedeh Fatemeh Razavipour & Hyunho Yoon & Kibeom Jang & Minsoon Kim & Hend M. Nawara & Amir Bagheri & Wei-Chi Huang & Miyoung Shin & Dekuang Zhao & Zhiqun Zhou & Derek Boven & Karoline Briegel & Llui, 2024. "C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer," Nature Communications, Nature, vol. 15(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0004710. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.